Trial
NCT03991741
Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
Gregory Daniels
Collaborators
Immunotherapy Foundation
Condition
Metastatic Melanoma
Intervention
Autologous Tumor Infiltrating Lymphocytes
Why stopped
Closed because of feasibility and safety issues, didn't reach our end point
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-03